journal article·2016-11-16Open access

Effect of functionalization on drug delivery potential of carbon nanotubes

Sonam Sharma, Neelesh Kumar Mehra, Keerti Jain, Narendra Kumar Jain

Abstract

The main aim of the present investigation was to explore the effect of functionalization on drug delivery potential of carbon nanotubes (CNTs) and to compare the in vitro and in vivo cancer targeting potential of doxorubicin HCL (DOX)-loaded ox-/multi-walled CNTs (MWCNTs), DOX-loaded PEG-MWCNTs and DOX-loaded FA-PEG-MWCNTs. The DOX/PEG-FA-MWCNTs showed enhanced cytotoxicity and were most preferentially taken up by the cancerous cells. The obtained results also support the extended resistance time and sustained release profile of drug-loaded surface-engineered MWCNTs. Overall, we concluded that the developed MWCNTs nanoformulations have higher cancer targeting potential.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Carbon Nanotubes in Composites · Graphene and Nanomaterials Applications · Fullerene Chemistry and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (21)

Show source-provided references
1. 10.1021/mp300701e10.1021/mp300701e ↗
2. 10.1016/j.carbon.2008.02.01210.1016/j.carbon.2008.02.012 ↗
3. 10.1016/j.addr.2011.04.00110.1016/j.addr.2011.04.001 ↗
4. 10.1038/354056a010.1038/354056a0 ↗
5. 10.1016/j.nano.2009.03.00110.1016/j.nano.2009.03.001 ↗
6. 10.3109/1061186X.2015.107784610.3109/1061186X.2015.1077846 ↗
7. 10.1016/j.colsurfa.2006.10.02210.1016/j.colsurfa.2006.10.022 ↗
8. 10.1021/nn700040t10.1021/nn700040t ↗
9. 10.3109/1061186X.2012.72921310.3109/1061186X.2012.729213 ↗
10. 10.1016/j.drudis.2015.01.00610.1016/j.drudis.2015.01.006 ↗
11. 10.3109/1061186X.2013.81302810.3109/1061186X.2013.813028 ↗
12. 10.1016/j.colsurfb.2015.04.05610.1016/j.colsurfb.2015.04.056 ↗
13. 10.3109/1061186X.2015.105557110.3109/1061186X.2015.1055571 ↗
14. 10.1021/mp500720a10.1021/mp500720a ↗
15. 10.1016/j.biomaterials.2014.02.02210.1016/j.biomaterials.2014.02.022 ↗
16. Mittal V · Int J Pharm Bio Sci · 2010 · 1 · 113
17. 10.1039/C4TB02123A10.1039/C4TB02123A ↗
18. 10.1002/mabi.20120047510.1002/mabi.201200475 ↗
19. 10.1016/j.biomaterials.2012.01.02510.1016/j.biomaterials.2012.01.025 ↗
20. Sharma P · Curr Drug Deliv · 2015
21. 10.1021/bm900162410.1021/bm9001624 ↗